A European, Observational, 3‐Year Cohort Comparative Study on the Safety of the Fixed Dose Combination Pravastatin 40 mg/Fenofibrate 160 mg vs. Statin Alone in Real Clinical Practice: The POSE Study

Documenti analoghi

• Impact of Regulatory Interventions on Ulipristal Acetate 5 mg (Esmya) Use in Spain: An Interrupted Time‐Series Analysis
  di: Marta Monreal‐Di Bello, et al.
  Pubblicazione: (2024)
• Prevalence, Associated Risk Factors, and Adverse Cardiovascular Outcomes of Statins Discontinuation: A Systematic Review
  di: Shahd A. Ageeb, et al.
  Pubblicazione: (2024)
• Development and Application of an Algorithm for Statin‐Induced Myopathy Based on Electronic Health Record‐Derived Structured Elements
  di: Akinyemi Oni‐Orisan, et al.
  Pubblicazione: (2025)
• Association Between Statins Use and Major Bleeding in Patients Using Direct Oral Anticoagulants for Atrial Fibrillation
  di: A. de Burgos‐González, et al.
  Pubblicazione: (2025)
• Hydrochlorothiazide Use and Risk of Skin Cancer: A Population‐Based Retrospective Cohort Study
  di: Avery Shuei‐He Yang, et al.
  Pubblicazione: (2024)